Literature DB >> 5767002

Public health aspects of relapsing tuberculosis.

O Horwitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5767002     DOI： 10.1164/arrd.1969.99.2.183

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  10 in total

1.  Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission.

Authors:  Ted Cohen; Caroline Colijn; Bryson Finklea; Megan Murray
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

2.  Modeling the impact of global tuberculosis control strategies.

Authors:  C J Murray; J A Salomon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

Review 3.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1970-05       Impact factor: 2.401

Review 4.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

5.  Risk factors for reactivation of tuberculosis in Manitoba.

Authors:  I L Johnson; M Thomson; J Manfreda; E S Hershfield
Journal:  CMAJ       Date:  1985-12-15       Impact factor: 8.262

6.  Emergent heterogeneity in declining tuberculosis epidemics.

Authors:  Caroline Colijn; Ted Cohen; Megan Murray
Journal:  J Theor Biol       Date:  2007-04-27       Impact factor: 2.691

7.  Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.

Authors:  Chia-Lin Tseng; Olivia Oxlade; Dick Menzies; Anne Aspler; Kevin Schwartzman
Journal:  BMC Public Health       Date:  2011-01-26       Impact factor: 3.295

8.  Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti.

Authors:  Vary Jacquet; Willy Morose; Kevin Schwartzman; Olivia Oxlade; Graham Barr; Franque Grimard; Dick Menzies
Journal:  BMC Public Health       Date:  2006-08-15       Impact factor: 3.295

9.  Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis.

Authors:  Jared B Ditkowsky; Kevin Schwartzman
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

10.  The relative fitness of drug-resistant Mycobacterium tuberculosis: a modelling study of household transmission in Peru.

Authors:  Gwenan M Knight; Mirko Zimic; Sebastian Funk; Robert H Gilman; Jon S Friedland; Louis Grandjean
Journal:  J R Soc Interface       Date:  2018-06       Impact factor: 4.118
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.